Calcitonin Gene Related Peptide (CGRP) - Pipeline Review, H1 2016 - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Calcitonin Gene Related Peptide (CGRP) - Pipeline Review, H1 2016" report to their offering.

This report provides comprehensive information on the therapeutic development for Calcitonin Gene Related Peptide (CGRP), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Calcitonin Gene Related Peptide (CGRP) and special features on late-stage and discontinued projects.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Key Topics Covered:

  1. Introduction
  2. Calcitonin Gene Related Peptide (CGRP) Overview
  3. Therapeutics Development
  4. Pipeline Products for Calcitonin Gene Related Peptide (CGRP) - Overview
  5. Pipeline Products for Calcitonin Gene Related Peptide (CGRP) - Comparative Analysis
  6. Calcitonin Gene Related Peptide (CGRP) - Therapeutics under Development by Companies
  7. Calcitonin Gene Related Peptide (CGRP) - Therapeutics under Investigation by Universities/Institutes
  8. Calcitonin Gene Related Peptide (CGRP) Products Glance
  9. Late Stage Products
  10. Clinical Stage Products
  11. Early Stage Products
  12. Calcitonin Gene Related Peptide (CGRP) - Products under Development by Companies
  13. Calcitonin Gene Related Peptide (CGRP) - Products under Investigation by Universities/Institutes
  14. Calcitonin Gene Related Peptide (CGRP) - Companies Involved in Therapeutics Development
  • Alder Biopharmaceuticals Inc.
  • BCN Peptides, S.A.
  • Boehringer Ingelheim GmbH
  • Eli Lilly and Company
  • BCN Peptides, S.A.
  • Teva Pharmaceutical Industries Ltd.
  • Noxxon Pharma AG

For more information visit http://www.researchandmarkets.com/research/7bfwcm/calcitonin_gene

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Endocrine and Metabolic Disorder Drugs, Musculoskeletal Disorders Drugs

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Endocrine and Metabolic Disorder Drugs, Musculoskeletal Disorders Drugs